This was also confirmed in public GEO datasets (Figure 6), where tumors displaying high target genes levels are BRAF-driven PTCs and ATCs, while most of the PDTCs of the series, characterized by RAS-like signaling, downregulate the same genes. The gene discussed is BRAF; the disease is Ehlers-Danlos syndrome, musculocontractural type.